Objective To assess the oncological outcomes of targeted microwave ablation (TMA) using organ‐based tracking (OBT) Fusion® via KOELIS Trinity® (KOELIS, Meylan, France) in men with intermediate‐risk prostate cancer (PCa): the VIOLETTE trial (ClinicalTrials.gov identifier: NCT04582656) Patients and Method In this prospective phase II, multicentre ...
Nicolas Barry Delongchamps +11 more
wiley +1 more source
The diagnostic value of inflammatory markers in bone metastasis of prostate cancer at initial prostate biopsy. [PDF]
Chen X +5 more
europepmc +1 more source
BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang +10 more
wiley +1 more source
Objective To describe the development and validation of the Prostate Cancer Electronic Health (eHealth) Literacy Instrument (P‐CeHLI). This is in response to: (i) a lack of clear and validated eHealth literacy measurement for men with prostate cancer; (ii) the unique information processing, decision making, and digital communication experience of men ...
Stuart Robert Jackson +6 more
wiley +1 more source
Impact of Approach Routes in MRI-Ultrasound Fusion Prostate Biopsy on Post-Biopsy Complications: A Propensity Score-Matched Analysis. [PDF]
Tanaka H +10 more
europepmc +1 more source
Diagnosis of penile cancer with ex vivo fluorescence confocal microscopy using the Histolog® Scanner
Objectives To evaluate the feasibility and diagnostic performance of ex vivo fluorescence confocal microscopy (FCM) using the Histolog® Scanner (SamanTree Medical SA, Lausanne, Switzerland) for the assessment of penile cancer (PeCa) specimens, and to compare FCM‐based diagnoses with standard formalin‐fixed, paraffin‐embedded (FFPE) histopathology ...
Xiaohu Zhang +8 more
wiley +1 more source
Development and External Validation of a Nomogram for Predicting Pain Risk Post-Transperineal Prostate Biopsy Using Multi-Parameter Analysis. [PDF]
Xu Y, Li X, Zhang Y, Xue P.
europepmc +1 more source
Transrectal prostate biopsy complications: a prospective single center study in a mid-income country. [PDF]
Schollemberg AJ +7 more
europepmc +1 more source
A clinical prostate biopsy dataset with undetected cancer. [PDF]
Chelebian E +5 more
europepmc +1 more source
Changes in the prostate biopsy landscape-how can we improve quality? [PDF]
Srivastava A, Borza T, Salami SS.
europepmc +1 more source

